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Abstract: We determine the association between eosinophilia and certain parasites diagnosed by 
serology in patients of subsaharan origin of a Primary Care Center from Madrid region, Spain. It 
was implemented a complete protocol for migrant patient to study eosinophilia and realized 
serology tests for parasites detection. All variable and data were evaluated by statistical methods. 
A total of 184 patients with eosinophilia were included in the study, 115 patients (62.5%) were 
seronegative for helminths and 69 were seropositive. Strongyloides stercoralis (55.07%), Schistosoma 
spp (39.13%) and Toxocara canis (20.29%) were the most prevalent helminths immunodetected in 
the study. So, 49 patients (26.6%) had abdominal pain, 50 patients (27.17%) had problems related 
with skin conditions and 38 patients (20.65%) had respiratory disorder, symptoms not related with 
the helminth parasites detected. Regarding number of parasites by patient, one specie was 
identified in 49 patients (26.63%) and two or more was identified in 20 patients (10.86%). 
Eosinophilia was resolved in 91.4% of parasite serpositive patients after received one specific 
adequate antiparasitic treatment, but this was resolved in 98.3% after received two tratments, and 
100% after the third. The results obtained allow us to make some reflections on the difficulty of 
managing these patients in the Primary Care Center and on whether to diagnose and treat 
individuals from endemic areas, with or without eosinophilia and being asymptomatic or not, 
given the benefit it has for the individual and public health, as possible to minimize any chance of 
transmission. 
Key words: Eosinophils, Migrants, Helminths, Primary Care Health. 
 
1. Introduction 
Eosinophilia is defined as an abnormal increase of eosinophils in peripheral blood and it is a 
condition that occurs relatively frequently in clinical practice. This immune response is associated 
with various pathologies, among others: allergic reactions, helminth parasites, gastrointestinal, 
hematological and lung disorders, and others like post-irradiation, bacterial infections, post-family 
hereditary pathologies or neoplastic disorders [1,2]. 
There is no consensus on the values considered normal in the eosinophil count in peripheral 
blood (absolute and relative), so in our study we defined eosinophilia as a number of more than 0.5 x 
109 eosinophils/ l (500 cells/ul in blood), or more than 4% in relative value [3, 4]. 
Eosinophilia is a common finding in immigrants which can indicate asymptomatic latent 
infection wich could lead to chronic disease and/or long-term complication [5]. In relation to 
subsaharan patients from tropical and subtropical areas, parasitoses are the main cause of 
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eosinophilia, being the prevalence of intestinal parasites in migrants ranges from 29% to 81%, 
depending on the country of origin. A number of parasitic characteristics that influence it, such as 
the number worms housed, adaptation of the parasitic species, life cycle of the worm, age of the 
process, re-infection and/or superinfection, intercurrent infectious processes and treatment with 
corticosteroids or anthelmintic treatment among others [1,6-7]. 
The subsaharan migration in Spain has been quantitatively limited and discontinuous [8]. In 
2014 the number of people from this source, according to the National Institute of Statistics, reached 
199.900 which corresponds to 22.4% of the total African migration and accounts for 4% of all 
migration into our country. The Spanish regions with the highest percentage of migrants from 
subsaharan countries registered in 2014 were Catalonia (33.43%), followed by Madrid (17.03%), 
Andalusia (16.39%) and Valencia (10.35%). These Autonomous Communities account for 77.2% of 
the total subsaharan migrants within the Spanish State. 
Migrants are generally young and healthy individuals, but those who came from developing 
countries may have latent infectious that need to be identified and treated. However there are a 
potentially generating aspects of the inequalities that affect this, such as the administrative 
difficulties to obtain their own Social Security Card; difficulties in their clinical history due to ethnic, 
cultural differences and problems with language; difficulties in diagnosis because they have 
non-autochthonous diseases, difficulties in the treatment as some treatments are not available in 
pharmacies and last difficulties in the epidemiological control [5, 9-13]. This makes the management 
of these patients in the Primary Care Center difficult and complicated. 
The basis of this study is the relationship between parasites and their influence on eosinophils 
in the blood of patients attended in a spanish Primary Care Center, since helminths are the group of 
parasites that trigger frequently the eosinophil increase in the subsaharan migration. Due to many 
times mild peripheal eosinophilia may be the only clue to detect helminths and recent studies 
suggest that relative eosinophilia is frequently associated with helminthic infection in migrant 
children from tropical and sub-tropical areas, so it seems logical a thorough parasitological study in 
this group of patients [14, 15]. 
Primary Care Health Centers are essential in carrying out the initial and comprehensive review 
of the health status of this population. We need to know about imported infectious diseases because 
of people move and flow from developing countries to European countries, in order to minimize the 
potential risk of several diseases. 
2. Patients and Methods 
The study was conducted at the Center for Primary Health Care "Brújula" located in Torrejon de 
Ardoz, Community of Madrid, Spain, during the period between 2012 and 2014. The study was 
reviewed and approved by the ethical committees and informed consent was obtained from 
patients. The inclusion critera were: i) patients from sub-saharian origin, ii) attended in primary care 
consultation for any reason and iii) give the informed consent. 
In our study, primary care physician implemented a complete protocol for migrant patient to 
study eosinophilia; it was designed to evaluate in every patient: medical history, epidemiologycal 
data (age, gender, country of origin, time sincde arrival to Spain, epidemiological risk factor), 
physical examination and several laboratory tests that includes complete blood count (absolute and 
relative eosinophil cell count included), biochemistry (including renal and liver function tests) and 
viral serology (HBV, HCV, HIV), performed routinely in the laboratory assigned to the center.  
Tests and serology for parasites detection was realized in the Serologic Diagnosis of Parasitic 
Diseases Unit National Microbiology Center, Institute of Health Carlos III, (ISCIII). 
For this, serum sample from each patient was referred to ISCIII to carry out the tests for specific 
IgG antibodies against the parasites. Commercial kits were used acording the manufacturer's 
instructions for the following parasites: Strongyloides spp (Strongyloides stercolaris IgG ELISA 
Diagnostic Kit, DRG, Marburg, Alemania), Toxocara spp. (Toxocara canis IgG ELISA Diagnostic Kit 
Novalisa TM Inmunodiagnostica GmbH, Alemania); Cysticercosis (Taenia solium IgG ELISA 
Diagnostic Kit Novalisa TM) and Schistosoma spp (Schistosoma mansoni IgG ELISA Diagnostic Kit 
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Novalisa TM). The following parasites were detected by techniques “in house” performed in the 
laboratory: Trichinella spp (Trichinella IgG Indirect immunofluorescent antibody test (IFAT), 
Fasciola spp (Fasciola hepatica IgG1 capture ELISA, lymphatic filariosis (Filarias total IgG and 
isotipes IgG1, IgG3 and IgG4 ELISA, Onchocercosis disease (Onchocerca total IgG and isotipes IgG1, 
IgG3 and IgG4 ELISA, Hydatidic disease (Echinococcus granulosus total IgG and isotipes IgG1 and 
IgG4 ELISA. 16-20 
3.1. Variable data 
All data (epidemiological, clinical and laboratorial variables) were collected on a laboratory 
notebook in which appeared the variables of each patient. A case was considered positive when the 
result was positive in serological test. Once identified patients with positive results against the tested 
helminths, they were given a proper treatment if they agreed to it, and after a period of time, it 
underwent a new identical to the initial serological test to check their negativization. In this study 
the tests described were conducted to obtain an accurate diagnosis, at an elevation of eosinophils 
and/µµµor presence of clinical symptoms.  
3.2. Statistical analyses 
The SPSS 20 statistical package was used for data analyses. Continuous variables were 
expressed as mean values and standard deviation, and categorical variables as number of cases and 
percentages. Cualitative variables were used, as Chi-Square Pearson or Fisher test, Relative Risk 
(RR) or Odds Ratio (OD) as required. 
As cuantitative variables, T-Student or ANOVA were used. Results were considered 
statistically significant if P value was < 0.05. 21,22 
3.3. Ethics 
All the procedures followed in this text were in accordance with the ethical standards of the 
responsible committee on human experimentation (institutional and regional) and with the Helsinki 
Declaration of 1975, as revised in 1983. 
3. Results 
The number of patients treated in this center during this period were 16.834, of whom 389 were 
from subsaharan origin, who were considered as the target population that represents 2.3% of all 
patients looked after at the Health Center. Subsaharan patients were of both sexes and different ages. 
During the period of study we lost cases as the result of change of address or Autonomous 
Community, return to their country of origin, rejection of treatment or once received it, do not 
performed the follow-up analytical control due to the possible loss of the right to health care, etc. 
Endly our final population and samples were 184 patients (47,30%). 
Patient’s baseline characteristics are shown in the Table I. In this sense It must be highlighted 
that 57.1% of the patients are women and the average age of our series was 38.4 years. The youngest 
patient studied was 14 years and the oldest, 85 years. The average total time of residence in Spain 
was 7.49 years, with a maximum of 41 years of residence. Of all the subsaharan Africa countries of 
origin of immigrants, Equatorial Guinea (32.6%), followed by Nigeria (31.0%) and Ghana (11.4%) are 
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Table I. Epidemiological data of Subsaharan migrant patients. 
 
Variable      N (1)    %(2) 
Sex     
Men       79    42,93  
Women      105    57,07 
 
Age (years old) 
≤19       8    4,35 
19-65      172    93,48 
65       4      
Median (IRQ)     38,4 (14-85)  2,17 
 
Time of residence in Spain, years (IRQ)*  7,5 (2-41)  
Travel to their origin country 
No       108    58,70 
Yes       8    4,35 
Indeterminad     68    36,96 
 
(1) (N=184) 
(2) % respect to the total patients 
IRQ: Interquartile range 
*In individuals to travel to their origin countryconsidering the time of residence from the date of their last 
return to Spain. 
 
With respect to the number an percentage of basal eosinophils of the 184 patients, 89 patients 
(48.37%) had eosinophilia. The average number of eosinophils in our entire population was 288 µl in 
absolute (range 86-400; SD 285) and 5.1% (range 1.9-7.5; SD 4.2) in relative values.  
From the total sample 69 patients (37.5%) showed positive serology to parasitosis and 115 (62.5%) 
were seronegative. With regard to the parasites diagnosed by serology in 69 patients, the results are 
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Table II. Parasites diagnosed by serology in sub-Saharan patients. 
 
Parasite   N (1)  N/Total patients (2) N/Patients with positive serology (3) 
Strongyloides   38  20,65    55,07 
stercoralis 
Schistosoma spp 27  14,67    39,13 
Toxocara canis  14  7,61     20,29 
Lymphatic   5  2,72     7,25 
filariasis   
Taenia solium  5  2,72     7,25 
Oonchocerca   4  2,17     5,80 
volvulus 
Echinococcus  1  0,54     1,45 
granulosus 
Trichinella spp 0  0,00     0,00 
Fasciola hepática 0  0,00     0,00 
 
 
(1) Number of patients with parasites 
(2) % among the 184 patients 
(3) % among the 69 patients with positive serology 
 
 
So the parasites that were diagnosed more frequently were, firstly, S. stercoralis, which appears 
in 38 patients (55.07%), followed by Schistosoma spp identified in 27 patients (39.13%), T. canis 
identified in 14 patients (20.29%) and T. solium in 5 patients (7.25%), O. volvulus in 4 patients 
(5.80%), and E. granulosus in 1 patient (1.45%); F. hepatica and Trichinella spp were not detected in 
any patient. From the 184 patients under study, 60 (32.60% of the total) came from Equatorial 
Guinea, endemic area for S. stercoralis; of these, 20 showed positive serology to it (28.99% of the 69 
parasitized patients and 33.33% of the 60 parasitized patients from Equatorial Guinea). 
Other microbiological diagnoses identified during the study, which could be related to several 
symptons (abdominal pain, skin conditions and respiratory disorder), are shown in Table III. We 
have not found significative relation between the serological diagnostic basal eosinophilia, parasites, 
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Table III. Relation of symptons and different variables in sub-Saharan patiens studied. 
 
    Abdominal pain   Skin disorders   Respiratory problems 
    __________________________________________________________________________ 
Variable   n %  P  n %  P  n %  P 
Sex  
Men    18 22,78  NS*  22 27,85  NS*  13 16,46  NS* 
Women   31 29,54    28 26,67    25 23,81 
Age 
≤19 years   3 37,50  NS**  2 25,00  NS**  2 25,00  NS** 
19-65 years   46 26,74    47 27,33    36 20,93 
≥65 years   0 0,00    1 25,00    0 0,00 
Basal eosinophilia 
No    23 24,21  NS*  23 24,21  NS*  15 15,79  NS* 
Yes    26 29,21    27 30,34    23 25,84 
Serology of tisular parasites 
No    35 30,43  NS*  29 25,22  NS*  27 23,48  NS*     
Yes    14 20,9    21 30,43    11 15,94 
Parasites in feaces 
No    19 31,15  NS**  21 34,43  NS¨**  16 26,23  NS**  
Yes    1 9,09    2 18,18    2 18,18 
Not realized  29 25,89    27 24,11    20 17,86 
VIH 
No    27 28,42  NS**  28 29,47  NS**  21 22,11  NS** 
Yes    3 27,27    4 36,36    1 9,09 
Not realized  19 24,36    18 23,08    16 20,51 
VHB 
No     11 25,58  NS*  12 27,91  NS*  12 27,91  NS** 
Yes     22 28,95    20 26,32    14 18,42 
Not realized  16 24,62    18 27,69    12 18,46 
VHC 
No    29 26,85  NS**  31 28,70  NS**  27 25,00  NS** 
Yes 
Not realized  18 26,09    17 24,64    10 14,49 
 
Total    49 26,63    50 27,17    38 20,65 
*Chi-Square Test 
** Fisher Test 
 
Respect the consideration of the basal eosinophilia as a diagnostic test (test problem) to detect 
tissue parasites identified by serology (reference test), the results observed in Table IV suggest that 
basal eosinophil parameter could be used as a diagnostic test because it shows a high negative 
predictive value (75.80%).  
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Table IV. Basal association between eosinophilia with or without parasites diagnosed by serology in 
sub-Saharan patients. 
 
      Without tisular parasites  With tisular parasites 
Basal eosinophilia  media mediana   P25-75  media mediana   P25-75   P (1) 
Eosinophils/µl  220  146      77-300  403  300      158-600    ≤0,001 
Eosinophils (%)  3,99  2,50     1,80-5,00  6,87  7,10     3,20-9,70    ≤0,001 
P25-P75= Interquartilic range 
N= Number of patients 
(1) U Mann-Whitney test 
 
The association between basal eosinophilia and the number of parasites detected by serology is 
showed in the Table V. In 115 patients (62.5%) no one agent was identified, one in 49 cases (26.63%) 
and more than one in 20 cases (10.86%).  
 
Table V. Basal association between eosinophilia as a continuous variable (eosinophils/µl) and % 




Nº Tissular helminths      Eosinophils/µl  Eosinophis (%) 
      media    220     3,99 
Nº parasites (n=115)  mediana    146     2,50 
      P25-75    77-300    1,80-5,00 
 
      media    325     5,72    
With one parasite (n=49) mediana    241     5,20   
      P25-75    122-479    1,90-8,60 
 
      media    593     9,68 
More than one parasite mediana    587     9,30   
(n=20)     P25-75    333-666    8,15-10,40 
      p*     ≤0,001    ≤0,001 
P25-P75= Interquartilic range 
N= number of patients 
*Kruskal-Wallis 
 
In addition, with regard to treatment, of the 69 patients with a positive result for parasitosis: 
three refused to be treated, 5 did not return to start treatment and 3 could not be submitted to 
analytical control after treatment. Finally were treated and evaluated 58 patients, who were given 
ivermectin in the case of Strongyloides spp and filaria; praziquantel for Schistosoma spp and Taenia 
spp; and albendazole for Toxocara spp. There was no real positive for Trichinella spp, Fasciola 
hepatica and Echinococcus spp and patients were not treated. It has been defined as a cure to the 
situation in which after administration of the specific treatment, a negative result was obtained in 
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the serological test carried out later. So, 91.4% of patients that received the first treatment showed 
complete resolution of the parasitosis diagnosed and eosinophilia; those who received the second 
treatment, complete resolution was seen in 98.3% and after the third treatment, complete resolution 
of eosinophilia was seen in 100%. 
 
4. Discussion 
In this study, carried out in a Primary Care Health, we have found a relation between “to have 
eosinophilia in peripheral blood and to have parasitosis” [23]. The exhaustive data from the clinic 
history of the patients of this study has allowed us to obtain some value information of diseases in 
asymptomatic patients. Prevalent rates between the presence of parasites and eosinophila range 
14%-64%, but others proposed a 75.9% of helminths or 77%, though it seems that frequency and 
distribution of parasites depends on the countries of origin of the migrants [5, 23-26]. 
A limitation of this study is that no all the helminths produce eosinophilia at the same level and 
most of the serology tests are not positive until 4-12 weeks after primo-infection [1, 23-24]. In this 
sense the results could be negative, but it is posible to have some parasitoses, although most of the 
migrants had been living in Spain for more than three months. 
We have found diarrhea, abdominal pain, gastroenteritis, skin disorders (eccem, prurit, micosis, 
dermatitis) and respiratory disorders (allergy, asthma, dermatitis, rinitis…) in a same way that other 
authors did [27]. In fact we have tried to evaluate these associations with VIH, VHB, VHC serology, 
helmiths serology with sociodemographic variables and eosinophilia, but we have not found any 
significative relation among them. 
In the same manner we have not found significative relation between sex and parasitism. It is 
possible that the time that migrants are in our country, so high (7.49 years media), may act as a 
“remedy” to eliminate some parasites after to have had a good hygiene, feed and health care [24, 
28-29]. 
The most frquent parasite found in our study was Strongyloides spp, followed by Schistosoma 
spp, and the hookworm Toxocara spp. However other studies conclude that filariosis is the most 
prevalent parasitosis but others found most prevalent the presence of schistosomosis or 
geohelminthiasis [5,25,26,30]. Such differences could be explained by the distinct geographical origin 
of patients and the geographical region in which the study was carried on.  
In serology we must taken into account the possibility to find cross-reactions as others authors 
have been proposed, being Strongyloides spp the parasite that more frequent was associated to 
poliparasitoses [24,25]. 
There are some controversy in relation to both diagnosis and treatment. Regarding how to deal 
with the migrant population from endemic areas of parasitosis, application of protocols to diagnose 
parasitic disease in migrant population has been questioned. According to some authors, this should 
not be systematic and indiscriminate, but it would have to conduct serological testing in patients 
presenting a risk factor. Others consider it should perform analytical screens even in asymptomatic 
migrants since some say that all migrants and travelers returning with eosinophilia, especially those 
from endemic areas, should be investigated, since 21% to 33% of them are asymptomatic and the 
interpretation of indirect diagnosis methods to detect Strongyloides spp, are complicated especially 
in case of poliparasitism 
In contrast, some experts argue administration of empirical treatment with ivermectin, 
albendazole and praziquantel. In fact, eosinophilia is resolved in over 90% of the patients treated 
empirically. For this, it is proposed a systematic evaluation of these patients because of none of the 
parasitic drugs has a 100% efficacy [14,25]. 
It seems logical that in migrants suspect helmintiasis and/or eosinophilia need protocols based 
on geographical risk of exposure. A systematic screening protocol could be applied for 
asymptomatic patients, including Strongyloides spp and Schistosoma spp serologies and others as 
HVI, HVB and HVC [14].  
During the development of this research, it was significant the promulgation of Royal 
Decree-Law 16/2012 that affected the model of the National Health System and the right to health 
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care in Spain was denied to a large number of migrants, aged over 18 years, without Social Security 
Card. The health care would be dispensed only in emergencies, serious illness or accident and 
pregnancy, childbirth and postpartum. The inmediately consequence was the no diagnostic or 
treatment of the migrant population, so diseases as tuberculosis or VHI infections were out of the 
health system with the subsequent individual and colective problems. 
Looking these results it looks logical to carry out studies to people that comes from endemic 
areas of parasitoses in order to prevent possible transmissions. So, the present study revealed that is 
neccesary to increase in Primary Care Health the evaluation of tropical diseases of migrant 
population, related with the origin country, time from the arrival to our country, visiting friends and 
relatives, social situation and conditions of life [30-33]. 
 
Conflicts of interest: Any author has no potential conflicts. 
 
References 
1 Pérez Arellano, JL.; Pardo, J.; Hernández Cabrera, M.; Carranza, C.; Angel Moreno, A.; Muro, A. 
Eoshinophilia: a practical approach. An Med Interna 2004, 21(5):244-52. 
2 Mejia, R.; Nutman, TB. Evaluation and differential diagnosis of marked, persistent eosinophilia. Semin 
Hematol 2012, 49(2):149-59.  
3 Leder, K.; Weller, PF. Eosinophilia and helminthic infections. Baillieres Best Pract Res Clin Haematol 2000, 
13(2):301-17. 
4 Valent, P.; Klio, AD.; Rosenwasser, LJ.; Arock, M.; Bochner, BS.; Butterfield, JH.; Gotlib, J.; Haferlach, T.; 
Hellmann, A.; Horny, HP.; Leiferman, KM.; Metzgeroth, G.; Matsumoto, K.; Reiter, A.; Roufosse, F.; 
Rothenberg, ME.; Simon, HU.; Sotlar, K.; Vandenberghe, P.; Weller, PF.; Gleich, GJ. ICON: Eosinophil 
Disorders. World Allergy Organ J 2012, 5(12):174-81.  
5 Monge-Maillo, B.; Jiménez, BC.; Pérez-Molina, JA.; Norman, F.; Navarro, M.; Pérez-Ayala, A.; Herrero, 
JM.; Zamarrón, P.; López-Vélez, R. Imported infectious diseases in mobile populations, Spain. Emerg 
Infect Dis 2009, 15(11):1745-52.  
6 Celestin, J.; Frieri, M. Eosinophilic disorders in various diseases. Curr Allergy Asthma Rep 2012, 
12(1):18-24.  
7 Valerio, L.; Roure, S.; Fernández-Rivas, G.; Basile, L.; Martínez-Cuevas, O.; Ballesteros, ÁL.; Ramos, X.; 
Sabrià, M.; North Metropolitan Working Group on Imported Diseases. Epidemiological and clinical 
characteristics of 70 cases diagnosed in the North Metropolitan Area of Barcelona, Spain, 2003-2012. Trans 
R Soc Trop Med Hyg 2013, 107(8):465-70. Strongyloides stercoralis, the hidden worm.  
8 Ahonen, EQ.; Porthé, V.; Vázquez, ML.; García, AM.; López-Jacob, MJ.; Ruiz-Frutos, C.; Ronda-Pérez, E.; 
Benach, J.; Benavides, FG. ITSAL Project. A qualitative study about immigrant workers' perceptions of 
their working conditions in Spain. J Epidemiol Community Health 2009, 63(11):936-42.  
9 López-Vélez, R.; Navarro Beltrá, M.; Hernando Jerez, A.; del Amo Valero, J. HIV infection in immigrants. 
Enferm Infecc Microbiol Clin 2008, 5:12-21. 
10 Saurina, C.; Vall-Llosera, L.; Saez, M. Factors determining access to and use of primary health care services 
in the Girona Health Region (Spain). Eur J Health Econ 2012, 13(4):419-27.  
11 Ehmsen, BK.; Biswas, D.; Jensen, NK.; Krasnik, A. Norredam, M. Undocumented migrants have diverse 
health problems. Dan Med J 2014, 61(9): A4897. 
12 Llop-Gironés, A.; Vargas Lorenzo, I.; Garcia-Subirats, I.; Aller, MB.; Vázquez Navarrete, ML. Immigrants' 
access to health care in Spain: a review. Rev Esp Salud Publica 2014, 88(6):715-34. 
13 Norman, FF.; López-Vélez, R. Immigration, helminths and eosinophilia: A complex triad. Travel Med 
Infect Dis 2015, 13(4):283-4. 
14 Meltzer, E.; Percik, R.; Shatzkes, J.; Sidi, Y.; Schwartz, E. Eosinophilia among returning travelers: a 
practical approach. Am J Trop Med Hyg 2008, 78(5):702-9. 
15 Belhassen-García, M.; Pardo-Lledias, J.; Pérez Del Villar, L.; Muro, A.; Velasco-Tirado, V.; Muñoz Bellido, 
JL.; Vicente, B.; Blázquez de Castro, A.; Cordero-Sánchez, M. Should parasitic disease be investigated in 
immigrant children with relative eosinophilia from tropical and sub-tropical regions? Paediatr Int Child 
Health 2016, 9:1-4.  
RIECS 2018, 3, 1 12 
 
16 Sulzer, AL. Indirect fluorescent test for parasitic diseases. Preparation of a stable antigen from larvae of 
Trichinella spiralis. J. Parasitol 1965, 51: 717-721. 
17 Muiño, L.; Perteguer, MJ.; Garate, T.; Martínez-Sernández, V.; Beltran, A.; Romaris, F.; Mezo, M.; 
Gonzalez-Warleta, M.; Ubeira, FM. Molecular and immunological characterization of Fasciola antigens 
recognized by the MM3 monoclonal antibody. Mol. Biochem. Parasitol 2011, 179(2): 80-90. 
18 Lawrence, RA.; Denham, DA. Stage and isotype specific immune responses in a rat model of filariasis. 
Parasite Immunol 1993, 15 (8): 429-439. 
19 Murdoch, ME.; Abiose, A.; Garate, T.; Hay, RJ.; Jones, BR.; Maizels, RM.; Parkhouse, RM. Human 
onchocerciasis in Nigeria: isotypic responses and antigen recognition in individuals with defined 
cutaneous pathology. Amm. Trop. Med. Hyg 1996, 54(6): 600-612. 
20 Güerri, ML.; Davila, M.; Rodríguez, M.; Nieto, FJ.; Ladrón de Guevara, C. Utility of IgG subclases in the 
diagnosis and folow up of the hidatidosis. Enferm Infecc. Microbiol. Clin 2000, 18(6): 262-266. 
21 Fleiss, JL. The design and analysis of clinical experiments. Wiley, New York, 1986. 
22 Kirkwood, BR. Essentials of medical statistics. Oxford; Blackwell Scientific Publications, 1988. 
23 Ehrhardt, S.; Burchard, GD. Eosinophilia in returning travelers and migrants. Dtsch Arztebl Int 2008, 
(46):801-7.  
24 Checkley, AM.; Chiodini, PL.; Dockrell, DH.; Bates, I.; Thwaites, GE.; Booth, HL.; Brown, M.; Wright, SG.; 
Grant, AD.; Mabey, DC.; Whitty, CJ.; Sanderson, F. British Infection Society and Hospital for Tropical 
Diseases. Eosinophilia in returning travellers and migrants from the tropics: UK recommendations for 
investigation and initial management. J Infect 2010, 60(1):1-20.  
25 Salas-Coronas, J.; Cabezas-Fernández, MT.; Vázquez-Villegas, J.; Soriano-Pérez, MJ.; Lozano-Serrano, AB.; 
Pérez-Camacho, I.; Cabeza-Barrera, MI.; Cobo, F. Evaluation of eosinophilia in immigrants in Southern 
Spain using tailored screening and treatment protocols: A prospective study. Travel Med Infect Dis 2015, 
13(4):315-21. 
26 Vilajeliu Balagué A, de Las Heras Prat P, Ortiz-Barreda G, Pinazo Delgado MJ, Gascón Brustenga J, Bardají 
Alonso, A. Imported parasitic diseases in the immigrant population in Spain. Rev Esp Salud Publica 2014, 
88(6):783-802.  
27 López-Vélez, R.; Huerga, H.; Turrientes, MC. Infectious diseases in immigrants from the perspective of a 
tropical medicine referral unit. Am J Trop Med Hyg 2003, 69(1):115-21. 
28 Díaz, J.; Igual, R.; Alonso, MC.; Moreno, JM. Estudio del parasitismo intestinal en inmigrantes de la 
comarca de La Safor (Comunidad Valenciana). Rev Med Clin 2002, (119): 1.  
29 López-Vélez, R.; Navarro Beltrán, M.; Jiménez Navarro, C. Estudio de Inmigración y Salud Pública: 
Enfermedades Infecciosas Importadas. Estudios, informe e investigación 2007. Ministerio de Sanidad y 
Consumo. 
30 Martín Sánchez, AM.; Hernández García, A.; González Fernández, M.; Afonso Rodríguez, O.; Hernández 
Cabrera, M.; Pérez Arellano, JL. Intestinal parasitosis in the asymptomatic Subsaharian immigrant 
population. Gran Canaria 2000. Rev Clin Esp 2004, 204(1):14-7.  
31 Roca, C.; Balanzó, X.; Fernández-Roure, JL.; Sauca, G.; Savall, R.; Gascón, J.; Corachán, M. Imported 
diseases in African immigrants in Spain: study of 1,321 patients. Med Clin (Barc) 2002, 119(16):616-9.  
32 Monge-Maillo, B.; López-Vélez, R.; Norman, FF.; Ferrere-González, F.; Martínez-Pérez, Á.; Pérez-Molina, 
JA. Screening of imported infectious diseases among asymptomatic subsaharan African and Latin 
American immigrants: a public health challenge. Am J Trop Med Hyg 2015, 92(4):848-56.  
33 Rodríguez Alvarez, E.; Lanborena Elordui, N.; Senhaji, M.; Pereda Riguera, C. Sociodemographic variables 
and lifestyle as predictors of self-perceived health in immigrants in the Basque Country [Spain]. Gac Sanit 
2008, 22(5):404-12. 
 
© 2018 por los autores; Esta obra está sujeta a la licencia de Reconocimiento 4.0 
Internacional de Creative Commons. Para ver una copia de esta licencia, visite 
http://creativecommons.org/licenses/by-nc-nd/4.0/.  
